Call Number (LC) Title Results
HE 20.3152:B 74/30 Moving beyond breast cancer. 1
HE 20.3152:B 74/979 Breast self-examination. 1
HE 20.3152:B 75 Genetic testing for breast cancer risk : it's your choice.
Genetic testing for breast cancer risk it's your choice /
2
HE 20.3152:B 75/999 Genetic testing for breast cancer risk : it's your choice. 1
HE 20.3152:B 75/2003 Genetic testing for breast cancer risk 1
HE 20.3152:B 85 Planning the 2001 bypass budget / 1
HE 20.3152:C 11 CaBIG® Lab Viewer search, display, and share clinical laboratory values to be transferred from clinical chemistry laboratory systems to clinical trials systems. 1
HE 20.3152:C 11/2 CaBIG® Central Clinical Participant Registry (C3PR) study participant registry. 1
HE 20.3152:C 11/3 CaBIG® Integration Hub clinical trials workflow integration. 1
HE 20.3152:C 11/4 CaBIG® Patient Study Calendar (PSC) clinical study participant schedule management. 1
HE 20.3152:C 16/2/981 Cancer : What to know, what to do about it. 1
HE 20.3152:C 16/3 Treating cancer. 1
HE 20.3152:C 16/4/rp.4 End results in cancer : report no. 4 / 1
HE 20.3152:C 16/4/rp. 4/supp Recent trends in survival of cancer patients, 1960-1971 / 1
HE 20.3152:C 16/4/rp.5 Cancer patient survival : report number 5 / 1
HE 20.3152:C 16/4/RPT.4 End results in cancer : report no. 4 / 1
HE 20.3152:C 16/5 Cancer centers program : information and guidelines on cancer center support grants / 1
HE 20.3152:C 16/5-2/974 The cancer centers program / 1
HE 20.3152:C 16/6/950-69 U.S. cancer mortality by county, 1950-1969 / 1
HE 20.3152:C 16/7 Cancer incidence in four member countries (Cyprus, Egypt, Israel, and Jordan) of the Middle East Cancer Consortium (MECC) compared with US SEER 1